VITTORIA BIOTHERAPEUTICS
Live / Registered — Registered (as of 03 Mar 2026)
What this means for you
Registered since 03 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97510062
- Registration number
- 8161625
- Mark type
- Word mark
- Filed
- 19 Jul 2022
- Published for opposition
- 20 Jun 2023
- Registered
- 03 Mar 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system
- Class 042 — Scientific and technological services: Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the creation of CAR T-cells
Owner
- ViTToria Biotherapeutics, Inc., Philadelphia, PA, US
- ViTToria Biotherapeutics, Inc., Philadelphia, PA, US
- ViTToria Biotherapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 03 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Jul 2025 — USE AMENDMENT FILED
- 25 Jan 2026 — SOU EXTENSION 4 GRANTED
- 25 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 21 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2025 — SOU EXTENSION 3 GRANTED
- 14 Feb 2025 — SOU EXTENSION 3 FILED
- 14 Feb 2025 — SOU TEAS EXTENSION RECEIVED